On May 22, Rocket Lab USA rose 4.48% in pre-market trading, trading at $130.4 USD/share, with trading volume of approximately $8.64 million. The rebound follows a sharp 6.76% pre-market decline the previous session triggered by the company's announcement of a common stock offering of up to $3 billion.
Rocket Lab filed to issue up to $3 billion in new common shares, marking the company's second major equity raise within two months, bringing cumulative equity financing to approximately $4.1 billion. The stated purpose includes potential acquisitions, though market commentators noted the vague language around deployment. The offering was announced at a time when the stock was trading near historic highs around $131, with some observers interpreting the timing as management capitalizing on elevated valuations — particularly ahead of SpaceX's reported $80 billion fundraise and potential public listing at a $1.7 trillion valuation.
The current pre-market recovery suggests partial stabilization after the initial dilution shock, as the stock attempts to reclaim levels above $130 within the broader context of a 131% post-earnings rally that preceded the recent technical correction phase.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments